Laboratoires URGO Urgotul AgSilver Singapur - anglès - HSA (Health Sciences Authority)

laboratoires urgo urgotul agsilver

hcp healthcare asia pte. ltd. - general hospital - urgotul ag/silver is indicated for the local treatment of wounds at risk or with signs of local infection: chronic wounds (pressure ulcers and leg ulcers) and acute wounds (partial thickness burns, dermabrasions, traumatic wounds, surgical wounds, etc). due to the non-adhesive nature of the dressing, urgotul ag/silver is recommended in the treatment of wounds in which the skin around the lesion is weakened.

Laboratoires Urgo URGOTUL Flexible lipido-colloid contact layer hydrocolloid dressing Singapur - anglès - HSA (Health Sciences Authority)

laboratoires urgo urgotul flexible lipido-colloid contact layer hydrocolloid dressing

hcp healthcare asia pte. ltd. - general & plastic surgery - urgotul is indicated for the management of; acute wounds (burns,traumatic wounds, abrasions, post-operative wounds) and chronic wounds (leg ulcers, pressure ulcers and diabetic foot ulcers) at the granulation and epithelialisation stage. epidermolysis bullosa (eb). flexible and very comformable, urgotul is especially suitable for difficult to dress or awkwardly placed wounds and for packing deep wounds.

Laboratoires Anios Dental Disinfectants Singapur - anglès - HSA (Health Sciences Authority)

laboratoires anios dental disinfectants

raydent supplies (s) pte ltd - dental - a substance that destroys harmful microorganisms or inhibit their activity on medical devices which are specific for dental purposes or for use in dental procedures. it is not intended for disinfection as end point of processing.

Laboratoires Anios Micro 10+ Singapur - anglès - HSA (Health Sciences Authority)

laboratoires anios micro 10+

raydent supplies (s) pte ltd - general hospital - concentrate for disinfecting and cleaning even the most delicate medical and dental instruments.

Laboratoires URGO Urgostart Plus Border Singapur - anglès - HSA (Health Sciences Authority)

laboratoires urgo urgostart plus border

hcp healthcare asia pte. ltd. - general hospital - urgostart plus border is indicated for all stages (from the desloughing stage to complete healing) of exuding wounds, including chronic wounds (leg ulcers, pressure ulcers, diabetic foot ulcers) and long standing acute wounds. the sacral format is recommended for wounds in the sacrum region (pressure ulcers).

Laboratoires URGO Urgostart Plus Singapur - anglès - HSA (Health Sciences Authority)

laboratoires urgo urgostart plus

hcp healthcare asia pte. ltd. - general hospital - urgostart plus is indicated for all stages (from the desloughing stage to complete healing) of exuding wounds, including chronic wounds (leg ulcers, pressure ulcers, diabetic foot ulcers) and long standing acute wounds.

Laboratoires URGO Urgostart Plus Pad Singapur - anglès - HSA (Health Sciences Authority)

laboratoires urgo urgostart plus pad

hcp healthcare asia pte. ltd. - general hospital - urgostart plus pad is indicated for all stages (from the desloughing stage to complete healing) of exuding wounds including chronic wounds (leg ulcers, pressure ulcers, diabetic foot ulcers) and long standing acute wounds.

IYUZEH- latanoprost ophthalmic solution 0.005% solution/ drops Estats Units - anglès - NLM (National Library of Medicine)

iyuzeh- latanoprost ophthalmic solution 0.005% solution/ drops

thea pharma inc. - latanoprost (unii: 6z5b6hvf6o) (latanoprost - unii:6z5b6hvf6o) - iyuzeh ™ (latanoprost ophthalmic solution) 0.005% is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. known hypersensitivity to latanoprost or any other ingredients in this product. risk summary there are no adequate and well-controlled studies of iyuzeh administration in pregnant women to inform drug-associated risks. in animal reproduction studies, intravenous (iv) administration of latanoprost to pregnant rabbits and rats throughout the period of organogenesis produced malformations, embryofetal lethality and spontaneous abortion at clinically relevant doses (equivalent to 1.3 – 324 times the maximum recommended human ophthalmic dose, on a mg/m 2 basis, assuming 100% absorption) (see data) . the background risk of major birth defects and miscarriage for the indicated population is unknown. however, the background risk in the u.s. general population of ma

Teoptic 1% eye drops Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

teoptic 1% eye drops

thea pharmaceuticals ltd - carteolol hydrochloride - eye drops - 10mg/1ml

Otrivine Antistin 0.5%/0.05% eye drops Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

otrivine antistin 0.5%/0.05% eye drops

thea pharmaceuticals ltd - antazoline sulfate; xylometazoline hydrochloride - eye drops - 5mg/1ml ; 500microgram/1ml